KFI
KURA icon

Key Financial Inc’s Kura Oncology KURA Stock Holding History

Key Financial Inc’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-360
Closed -$3.31K – 1477
2025
Q3 		$3.31K Hold
360
– – ﹤0.01% 1122
2025
Q2 		$2.08K Hold
360
– – ﹤0.01% 1181
2025
Q1 		$2.38K Hold
360
– – ﹤0.01% 1125
2024
Q4 		$3.14K Hold
360
– – ﹤0.01% 1084
2024
Q3 		$7.03K Hold
360
– – ﹤0.01% 878
2024
Q2 		$7.41K Hold
360
– – ﹤0.01% 849
2024
Q1 		$7.68K Hold
360
– – ﹤0.01% 825
2023
Q4 		$5.18K Hold
360
– – ﹤0.01% 917
2023
Q3 		$3.28K Hold
360
– – ﹤0.01% 1042
2023
Q2 		$3.81K Hold
360
– – ﹤0.01% 1036
2023
Q1 		$4.4K Hold
360
– – ﹤0.01% 833
2022
Q4 		$4.92K Hold
360
– – ﹤0.01% 792
2022
Q3 		$5K Hold
360
– – ﹤0.01% 792
2022
Q2 		$7K Hold
360
– – ﹤0.01% 720
2022
Q1 		$6K Hold
360
– – ﹤0.01% 750
2021
Q4 		$5K Sell
360
-360
-50% -$5.83K ﹤0.01% 718
2021
Q3 		$13K Buy
+720
New +$13.6K 0.01% 530

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Key Financial Inc's KURA Position: Q4 2025 in Review

Key Financial Inc sold out of Kura Oncology (KURA) in Q4 2025, closing a stake of 360 shares — an estimated $3.31K sold.

Key Financial Inc first reported a position in KURA in Q3 2021 and held it in 17 quarters. The position peaked at $13K in Q3 2021. 215 funds tracked by Wall St. Rank hold KURA as of Q4 2025.

  • Key Financial Inc reported no remaining Kura Oncology position as of Q4 2025 after selling out during the quarter.
  • Key Financial Inc sold 360 Kura Oncology shares in Q4 2025, an estimated $3.31K.
  • Key Financial Inc first reported a position in Kura Oncology in Q3 2021 and held it in 17 quarters.
  • Key Financial Inc's Kura Oncology position peaked at $13K in Q3 2021.
  • 215 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2025.

Based on Key Financial Inc's 13F filing for Q4 2025, filed 9 Feb 2026.